We conducted a multicenter , randomized , double-blind , placebo-controlled trial of caspofungin as antifungal prophylaxis in @ adults who were in the ICU for at least @ days , were ventilated , received antibiotics , had a central line , and had @ additional risk factor ( parenteral nutrition , dialysis , surgery , pancreatitis , systemic steroids , or other immunosuppressants ) .